Could hormones influence how women respond to psilocybin and other psychedelics? New research is drawing attention to an important but surprisingly underexplored area of psychedelic science: the role of female sex hormones.
Interest in psilocybin research has grown enormously in recent years, with scientists investigating everything from its effects on the brain to its potential role in future approaches to mental health.
But there is another variable researchers are beginning to look at more closely: hormones.
A recent scientific paper published in Molecular Psychiatry explores the potential relationship between female sex hormones and psychedelic effects, raising an intriguing question:
Could hormonal changes throughout a woman’s life alter how the brain and body respond to psychedelics such as psilocybin?
At the moment, there isn’t enough evidence to give us a definitive answer. But researchers argue there are good scientific reasons to investigate.
Why Are Researchers Interested in Hormones and Psychedelics?
Hormones aren’t simply involved in reproduction. They interact with numerous systems throughout the body, including the brain.
Two particularly important hormones are estradiol, a form of oestrogen, and progesterone.
Levels of these hormones can change considerably during:
- the menstrual cycle
- pregnancy and the postpartum period
- perimenopause and menopause
- use of hormonal contraception
- hormone-based treatments
These changes can influence mood, cognition, brain function and other physiological processes.
Researchers are therefore questioning whether hormonal variation could also be an overlooked factor in psychedelic research.
Psilocybin and the Serotonin System
One reason the question is particularly interesting involves serotonin.
Psilocybin is converted within the body into psilocin, which interacts with serotonin receptors in the brain.
One receptor in particular – the 5-HT2A receptor – plays an important role in the characteristic effects associated with classic psychedelics.
Research into psilocybin has repeatedly highlighted the importance of this receptor and the wider changes in brain activity associated with psychedelic states.
Sex hormones can also interact with serotonin signalling.
This creates an interesting possibility for researchers: if hormone levels influence aspects of the serotonin system, could changes in those hormones also affect psychedelic response?
It is a biologically plausible question – but importantly, plausible does not mean proven.
Could the Menstrual Cycle Affect Psychedelic Response?
This is one of the most interesting questions raised by this emerging area of research.
Estradiol and progesterone fluctuate throughout the menstrual cycle.
Researchers have therefore suggested that different phases of the cycle could theoretically influence factors such as:
- sensitivity to psychedelic compounds
- subjective experiences
- emotional responses
- side effects
- drug metabolism
- potential therapeutic outcomes
However, direct human research examining these relationships remains extremely limited.
That means it would be premature to claim that psilocybin produces predictably different effects during different stages of the menstrual cycle.
Instead, researchers are highlighting something much more fundamental:
We need better studies.
Future psychedelic trials could potentially record menstrual cycle stage and hormone levels rather than treating sex as a single fixed variable.
What About Hormonal Contraception?
Hormonal contraception adds another interesting layer.
Millions of women use contraceptive methods that alter normal hormonal patterns, yet this isn’t necessarily treated as a major variable in psychedelic studies.
Researchers are questioning whether future trials should examine participants using hormonal contraception separately from those experiencing naturally fluctuating menstrual cycles.
Again, there isn’t currently enough evidence to say that contraception changes a person’s response to psilocybin.
The point is that researchers may need to start measuring these differences before we can know whether they matter.
Pregnancy and the Postpartum Period
Pregnancy and the months following birth involve some of the most dramatic hormonal changes experienced during adult life.
They are also periods in which vulnerability to certain mental health conditions can change.
As psychedelic-assisted therapies continue to be investigated, researchers argue that women’s reproductive health needs to become a more prominent part of the conversation.
This doesn’t mean psychedelics have been demonstrated to be safe or effective during pregnancy or breastfeeding – they have not.
Instead, it highlights how much remains unknown and why carefully designed research into women’s mental health is important.
What About Perimenopause and Menopause?
Another potentially significant area is menopause.
During perimenopause, levels of hormones including oestrogen and progesterone can fluctuate considerably before eventually declining.
These hormonal changes can coincide with changes in mood, sleep, cognition and emotional wellbeing.
At the same time, psychedelic research is increasingly investigating conditions that can affect people during midlife.
Yet the interaction between menopause, hormonal status and psychedelic response remains poorly understood.
Future research may therefore need to consider menopausal status and hormone therapy when analysing psychedelic clinical trials.
Could Hormones Affect How Psilocybin Is Processed by the Body?
The relationship might not be limited to the brain.
Hormones can influence several processes involved in how drugs move through and are processed by the body, including gastrointestinal function and liver enzyme activity.
Researchers have therefore proposed that hormonal variation could potentially affect the pharmacokinetics of psychedelics – essentially how a compound is absorbed, distributed, metabolised and eliminated.
For psilocybin specifically, however, direct human evidence demonstrating a meaningful hormonal effect on its pharmacokinetics is currently lacking.
This is another area where the question is currently more developed than the answer.
Why Women’s Psychedelic Research Matters
The wider issue highlighted by this research extends beyond psilocybin.
Historically, biological differences associated with female reproductive hormones haven’t always been adequately incorporated into medical research.
But treating women as one biologically static group can overlook substantial changes occurring across the lifespan.
A 25-year-old using hormonal contraception, a woman in the postpartum period and someone experiencing perimenopause may have very different hormonal environments.
If hormones ultimately prove to influence psychedelic response, those differences could become important when scientists design clinical trials and interpret their results.
So, Do Hormones Change How Women Respond to Psilocybin?
We don’t know yet.
And that’s arguably what makes this research so interesting.
There are plausible biological mechanisms suggesting that hormones could influence psychedelic response, including interactions involving serotonin signalling, brain function and drug metabolism.
But the direct human evidence remains limited.
Rather than providing a definitive answer, this research identifies a gap in our understanding – and provides scientists with a roadmap for investigating it.
Future psychedelic studies may increasingly need to consider factors including menstrual cycle stage, hormonal contraception, pregnancy and postpartum status, menopause and hormone therapies.
Doing so could help researchers build a much more detailed understanding of why psychedelic experiences and clinical outcomes may vary between individuals.
The Next Chapter of Psychedelic Research?
Psychedelic science has advanced rapidly, but increasingly sophisticated research is revealing just how many questions remain unanswered.
The next stage may not simply be about asking whether psilocybin has an effect.
It may be about understanding why effects differ between people – and which biological factors influence those differences.
Hormones could prove to be one piece of that puzzle.
For now, the evidence isn’t strong enough to draw firm conclusions.
But the fact researchers are beginning to ask these questions represents an important step towards a more nuanced understanding of psychedelics, the brain and women’s mental health.
About This Research
This article discusses emerging scientific research and should not be interpreted as medical advice or evidence supporting the use of psilocybin for any medical condition.
The research discussed is exploratory and highlights areas requiring further investigation. Psilocybin-containing mushrooms are controlled substances in the UK, and OnlySpores products are sold strictly for lawful microscopy and research purposes.
Source: Molecular Psychiatry (2026), Nature Portfolio – research examining the potential relationship between female sex hormones and psychedelic response.
